Eupraxia Pharmaceuticals Inc. EPRX.TO Stock
Eupraxia Pharmaceuticals Inc. Price Chart
Eupraxia Pharmaceuticals Inc. EPRX.TO Financial and Trading Overview
| Eupraxia Pharmaceuticals Inc. stock price | 3.7 CAD |
| Previous Close | 7.5 CAD |
| Open | 7.75 CAD |
| Bid | 7.5 CAD x N/A |
| Ask | 7.64 CAD x N/A |
| Day's Range | 7.4 - 7.75 CAD |
| 52 Week Range | 0.89 - 7.99 CAD |
| Volume | 35.89K CAD |
| Avg. Volume | 17.82K CAD |
| Market Cap | 165.01M CAD |
| Beta (5Y Monthly) | 1.170873 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.53 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.02 CAD |
EPRX.TO Valuation Measures
| Enterprise Value | 153.67M CAD |
| Trailing P/E | N/A |
| Forward P/E | -4.4327483 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 19.093199 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -6.286 |
Trading Information
Eupraxia Pharmaceuticals Inc. Stock Price History
| Beta (5Y Monthly) | 1.170873 |
| 52-Week Change | 589.09% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 7.99 CAD |
| 52 Week Low | 0.89 CAD |
| 50-Day Moving Average | 6.35 CAD |
| 200-Day Moving Average | 4.26 CAD |
EPRX.TO Share Statistics
| Avg. Volume (3 month) | 17.82K CAD |
| Avg. Daily Volume (10-Days) | 27.32K CAD |
| Shares Outstanding | 21.77M |
| Float | 13.24M |
| Short Ratio | 5.51 |
| % Held by Insiders | 12.22% |
| % Held by Institutions | 20.15% |
| Shares Short | 126.15K |
| Short % of Float | 1.41% |
| Short % of Shares Outstanding | 0.57% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -65.31% |
| Return on Equity (ttm) | -215.58% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -24445916 CAD |
| Net Income Avi to Common (ttm) | -24528468 CAD |
| Diluted EPS (ttm) | -1.3 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 18.85M CAD |
| Total Cash Per Share (mrq) | 0.87 CAD |
| Total Debt (mrq) | 10.82M CAD |
| Total Debt/Equity (mrq) | 153.27 CAD |
| Current Ratio (mrq) | 8.82 |
| Book Value Per Share (mrq) | 0.397 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -21056280 CAD |
| Levered Free Cash Flow (ttm) | -13397814 CAD |
Profile of Eupraxia Pharmaceuticals Inc.
| Country | Canada |
| State | BC |
| City | Victoria |
| Address | 2067 Cadboro Bay Road |
| ZIP | V8R 5G4 |
| Phone | 250-590-3968 |
| Website | https://www.eupraxiapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 21 |
Eupraxia Pharmaceuticals Inc., a clinical stage biotechnology company, engages in the discovery, development, and marketing of technologies in the biotechnology sector. The company's lead product candidate is EP-104IAR, which is in a Phase II clinical trial for the treatment of unmet medical needs and for pain relief for knee osteoarthritis and eosinophilic esophagitis, as well as under development for treating canine osteoarthritis. Its products in development also include EP-201, an antibiotic for post-surgical site infections; and EP-105, an extended-release post-surgical anesthetic for post-surgical pain. In addition, the company develops product candidates for oncology. The company was formerly known as Plaza Capital Partners Inc. and changed its name to Eupraxia Pharmaceuticals Inc. in May 2012.Eupraxia Pharmaceuticals Inc. was incorporated in 2011 and is headquartered in Victoria, Canada.
Q&A For Eupraxia Pharmaceuticals Inc. Stock
What is a current EPRX.TO stock price?
Eupraxia Pharmaceuticals Inc. EPRX.TO stock price today per share is 3.7 CAD.
How to purchase Eupraxia Pharmaceuticals Inc. stock?
You can buy EPRX.TO shares on the Toronto exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Eupraxia Pharmaceuticals Inc.?
The stock symbol or ticker of Eupraxia Pharmaceuticals Inc. is EPRX.TO.
Which industry does the Eupraxia Pharmaceuticals Inc. company belong to?
The Eupraxia Pharmaceuticals Inc. industry is Biotechnology.
How many shares does Eupraxia Pharmaceuticals Inc. have in circulation?
The max supply of Eupraxia Pharmaceuticals Inc. shares is 35.62M.
What is Eupraxia Pharmaceuticals Inc. Price to Earnings Ratio (PE Ratio)?
Eupraxia Pharmaceuticals Inc. PE Ratio is now.
What was Eupraxia Pharmaceuticals Inc. earnings per share over the trailing 12 months (TTM)?
Eupraxia Pharmaceuticals Inc. EPS is -1.53 CAD over the trailing 12 months.
Which sector does the Eupraxia Pharmaceuticals Inc. company belong to?
The Eupraxia Pharmaceuticals Inc. sector is Healthcare.